RxDoctor Payments DataLook up a doctor →

Bobbi Lee Roth

Family · Tualatin, ORNPI 1558890848

Payments from drug & device makers

$23,013in general payments, 2019–2025

Across 893 payments — averaging $25.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Sanofi$6K
  • EMD Serono, Inc.$1K
  • Biogen$1K
  • UCB, Inc.$1K
  • AbbVie$1K
  • Neurocrine Biosciences, Inc.$1K
  • plus $10K from 46 others

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Sanofi51$5,901
EMD Serono, Inc.42$1,494
Biogen92$1,485
UCB, Inc.86$1,456
AbbVie(2 entities)77$1,233
Neurocrine Biosciences, Inc.40$1,218
Novartis37$1,110
SK Life Science, Inc.46$896
Genentech USA, Inc.27$606
Pfizer44$590
Amneal Pharmaceuticals LLC22$457
TG Therapeutics, Inc.9$451
Amgen(2 entities)20$429
AstraZeneca13$423
Argenx US, Inc.14$413
Bristol Myers Squibb23$361
Lundbeck LLC18$358
Impel Pharmaceuticals Inc.18$331
Johnson & Johnson(2 entities)19$330
Takeda Pharmaceuticals U.S.A., Inc.17$325
MDD US Operations, LLC14$310
Otsuka America Pharmaceutical, Inc.7$279
Teva Pharmaceuticals USA, Inc.30$239
Lilly USA, LLC12$238
ANI Pharmaceuticals, Inc.9$211
Neurelis, Inc.9$187
Biohaven Pharmaceutical Holding Company Ltd.16$182
Acadia Pharmaceuticals Inc8$152
Merz Pharmaceuticals, LLC5$143
Kyowa Kirin, Inc.8$143
Octapharma USA, Inc.6$131
Jazz Pharmaceuticals Inc.4$108
CSL Behring6$101
Banner Life Sciences, LLC7$101
Eisai Inc.4$81
Scilex Pharmaceuticals Inc.4$69
Sunovion Pharmaceuticals Inc.6$57
Biohaven Pharmaceuticals, Inc.4$56
Axsome Therapeutics, Inc.2$47
Boston Scientific2$45
Grifols USA, LLC2$39
Tanabe Pharma America, Inc.2$35
Impel Pharmaceuticals LLC2$29
Otsuka Pharmaceutical Development & Commercialization, Inc.1$27
Livanova USA, Inc.1$22
Cala Health, Inc.1$20
Sumitomo Pharma America, Inc.1$20
Aquestive Therapeutics, Inc.1$18
Xeris Pharmaceuticals, Inc.1$17
Catalyst Pharmaceuticals, Inc.1$16
Averitas Pharma Inc.1$15
Aucta Pharmaceuticals, Inc.1$10

How this compares

$23,013 in reported general payments places this provider in the 95th percentile of 1,130 family providers in Oregon.

See all family providers in Oregon →

Medicare billing

Part B allowed, 2024
$63,773
Medicare patients
266
Services billed
571

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family in Tualatin

See the full list for Oregon →

Where these figures come from

Is this you, or does something look wrong? →